Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 461

1.

The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.

Pezeshki A, Ovsyannikova IG, McKinney BA, Poland GA, Kennedy RB.

Expert Rev Vaccines. 2019 Jan 31:1-15. doi: 10.1080/14760584.2019.1575208. [Epub ahead of print]

PMID:
30700167
2.

Current perspectives in assessing humoral immunity after measles vaccination.

Haralambieva IH, Kennedy RB, Ovsyannikova IG, Schaid DJ, Poland GA.

Expert Rev Vaccines. 2019 Jan;18(1):75-87. doi: 10.1080/14760584.2019.1559063. Epub 2018 Dec 26.

PMID:
30585753
3.

Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives.

Muhsen IN, Aljurf M, Wingard JR, Poland GA, Komanduri KV, Whitaker JA, Hashmi SK.

Vaccine. 2018 Oct 1;36(41):6043-6052. doi: 10.1016/j.vaccine.2018.08.044. Epub 2018 Sep 6. Review.

PMID:
30195488
4.

Strategies to maximize influenza vaccine impact in older adults.

Whitaker JA, von Itzstein MS, Poland GA.

Vaccine. 2018 Sep 25;36(40):5940-5948. doi: 10.1016/j.vaccine.2018.08.040. Epub 2018 Aug 25. Review.

PMID:
30153995
5.

Detection and Quantification of Influenza A/H1N1 Virus-Specific Memory B Cells in Human PBMCs Using ELISpot Assay.

Haralambieva IH, Ovsyannikova IG, Kennedy RB, Poland GA.

Methods Mol Biol. 2018;1808:221-236. doi: 10.1007/978-1-4939-8567-8_19.

PMID:
29956187
6.

Influenza vaccine failure: failure to protect or failure to understand?

Poland GA.

Expert Rev Vaccines. 2018 Jun;17(6):495-502. doi: 10.1080/14760584.2018.1484284. Epub 2018 Jun 26. Review.

PMID:
29883218
7.

Knowledge gaps persist and hinder progress in eliminating mumps.

Ramanathan R, Voigt EA, Kennedy RB, Poland GA.

Vaccine. 2018 Jun 18;36(26):3721-3726. doi: 10.1016/j.vaccine.2018.05.067. Epub 2018 May 18. Review.

PMID:
29784466
8.

Immunization education for internal medicine residents: A cluster-randomized controlled trial.

Whitaker JA, Poland CM, Beckman TJ, Bundrick JB, Chaudhry R, Grill DE, Halvorsen AJ, Huber JM, Kasten MJ, Mauck KF, Mehta RA, Olson T, Thomas KG, Thomas MR, Virk A, Wingo MT, Poland GA.

Vaccine. 2018 Mar 27;36(14):1823-1829. doi: 10.1016/j.vaccine.2018.02.082. Epub 2018 Feb 26.

PMID:
29496350
9.

Development of vaccines against Zika virus.

Poland GA, Kennedy RB, Ovsyannikova IG, Palacios R, Ho PL, Kalil J.

Lancet Infect Dis. 2018 Jul;18(7):e211-e219. doi: 10.1016/S1473-3099(18)30063-X. Epub 2018 Jan 26. Review.

PMID:
29396004
10.

Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.

Haralambieva IH, Kennedy RB, Simon WL, Goergen KM, Grill DE, Ovsyannikova IG, Poland GA.

PLoS One. 2018 Jan 30;13(1):e0191812. doi: 10.1371/journal.pone.0191812. eCollection 2018.

11.

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.

Teresa Aguado M, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, Hyde TB, Jit M, Jones R, Poland GA, Friede M, Ortiz JR.

Vaccine. 2018 Feb 8;36(7):921-931. doi: 10.1016/j.vaccine.2017.12.029. Epub 2018 Jan 12.

12.

Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering.

Voigt EA, Grill DE, Zimmermann MT, Simon WL, Ovsyannikova IG, Kennedy RB, Poland GA.

Sci Rep. 2018 Jan 15;8(1):739. doi: 10.1038/s41598-017-17735-x.

13.

Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Voigt EA, Haralambieva IH, Larrabee BL, Kennedy RB, Ovsyannikova IG, Schaid DJ, Poland GA.

J Infect Dis. 2018 Jan 30;217(4):560-566. doi: 10.1093/infdis/jix538.

14.

Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

Haralambieva IH, Gibson MJ, Kennedy RB, Ovsyannikova IG, Warner ND, Grill DE, Poland GA.

PLoS One. 2017 Nov 16;12(11):e0188149. doi: 10.1371/journal.pone.0188149. eCollection 2017.

15.

Personalized vaccinology: A review.

Poland GA, Ovsyannikova IG, Kennedy RB.

Vaccine. 2018 Aug 28;36(36):5350-5357. doi: 10.1016/j.vaccine.2017.07.062. Epub 2017 Jul 31. Review.

PMID:
28774561
16.

Vaccinology in the 21st century-The 10th Annual Vaccine Congress.

Kostova EB, Poland GA.

Vaccine. 2017 Aug 16;35(35 Pt A):4451-4452. doi: 10.1016/j.vaccine.2017.07.015. Epub 2017 Jul 15. No abstract available.

PMID:
28720282
17.

Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell Populations.

Zimmermann MT, Kennedy RB, Grill DE, Oberg AL, Goergen KM, Ovsyannikova IG, Haralambieva IH, Poland GA.

Front Immunol. 2017 Apr 21;8:445. doi: 10.3389/fimmu.2017.00445. eCollection 2017.

18.

Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.

Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Zimmermann MT, Grill DE, Schaid DJ, Poland GA.

Hum Genet. 2017 Apr;136(4):421-435. doi: 10.1007/s00439-017-1768-9. Epub 2017 Mar 13.

19.

Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.

Ovsyannikova IG, Larrabee BR, Schaid DJ, Poland GA.

Vaccine. 2017 Oct 4;35(41):5444-5447. doi: 10.1016/j.vaccine.2017.02.046. Epub 2017 Mar 6.

20.

Heritability of vaccine-induced measles neutralizing antibody titers.

Schaid DJ, Haralambieva IH, Larrabee BR, Ovsyannikova IG, Kennedy RB, Poland GA.

Vaccine. 2017 Mar 7;35(10):1390-1394. doi: 10.1016/j.vaccine.2017.01.078. Epub 2017 Feb 8.

Supplemental Content

Loading ...
Support Center